Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for postoperative sleep in gastric cancer
NCT03117023Phase 3Unknown
- Sponsor
- General Hospital of Eastern Military Command
- Start
- Apr 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of dexmedetomidine in Postoperative sleep disturbance (PSD) and postoperative pain (2 arms), sponsored by General Hospital of Eastern Military Command. Primary endpoint: Total sleep time. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Postoperative sleep disturbance (PSD)postoperative pain
Beyond the preview
Go deeper on NCT03117023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03117023.